FDA CAUGHT IN POLITICAL CROSSFIRE
Applied Clinical Trials
; 30(10):6, 2021.
Artigo
em Inglês
| ProQuest Central | ID: covidwho-20244568
ABSTRACT
FDA's oversight of medical devices and diagnostics has put it in the hot seat for shortages of critical products for protecting medical personnel and for providing fast and accurate public testing for COVID infection. The result is that the White House has delayed in selecting an FDA commissioner, even though federal rules require Woodcock to vacate her acting position by mid-November unless the administration nominates a new commissioner, permitting her to continue on during the Senate confirmation process. The approval decision by CDER officials was blasted by members of Congress, the medical community and even some patient groups, but justified by the reviewers as likely to provide some benefit to some patients who lacked any alternative treatment for this devastating disease.
Buscar no Google
Coleções:
Bases de dados de organismos internacionais
Base de dados:
ProQuest Central
Tipo de estudo:
Estudo experimental
/
Ensaios controlados aleatorizados
Idioma:
Inglês
Revista:
Applied Clinical Trials
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS